Biocept, Inc. (BIOC)
BIOC Price and Sentiment
BIOC Latest news
Biocept says study shows its Switch-Blocker technology enhances performance of PCR-based liquid biopsy assays in detecting rare cancer mutations2021-11-09 10:52
Biocept Inc (NASDAQ:BIOC) has announced the publication of a study showing that the addition of Switch-Blocker technology to common PCR-based liquid biopsy assays significantly increased sensitivity in detecting rare cancer mutations. The abstract was published in the November 2021 issue of the “Journal of Molecular Diagnostics.
Study Shows Biocept's Switch-Blocker Technology Enhances Performance of Conventional PCR-Based Liquid Biopsy Assays in Detecting Rare Cancer Mutations2021-11-09 08:17
SAN DIEGO--(BUSINESS WIRE)--Published abstract shows Biocept's Switch-Blocker technology increases the sensitivity of liquid biopsy assays for detecting rare cancer mutations.
Biocept to Report Third Quarter 2021 Financial Results and Host Investor Conference Call on November 15, 20212021-11-08 08:00
SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it will release financial results for the three and nine months ended September 30, 2021 after the market closes on Monday, November 15, 2021. The Company will host an investor conference call to discuss the results and answer questions at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). Date/Time: Monday, November 15, 4:30 p.m. ET / 1:30 p.m. PT P
SAN DIEGO--(BUSINESS WIRE)---- $BIOC #LD_Micro--Biocept to present at LD Micro Main Event
Battling cancer is often a long journey—and one that becomes even more challenging for the large number of patients who find that the cancer may have spread to their brain or spinal cord. Between 10% and 30% of cancer patients, and a much higher percentage of late-stage cancer patients will develop brain or spinal cord metastasis.
Biocept implements COVID-19 testing services at more than 30 community college campuses across California2021-09-22 09:25
Biocept Inc has implemented its COVID-19 testing services at more than 30 community college campuses across California. Also, the company said it is streamlining the testing and tracking process for administrators, and allowing students and staff to easily schedule and complete COVID-19 testing.
Biocept Implements COVID-19 Testing Program at Select California Community Colleges, Supporting Testing Needs for Students and Staff Amid Pandemic2021-09-22 08:17
SAN DIEGO--(BUSINESS WIRE)--Biocept provides on-campus COVID-19 testing to over 30 California community colleges, as students and staff return to in-person learning.
These penny stocks are undervalued based on their fundamentals and have the potential to break through in the coming months. The post 7 of the Best Penny Stocks to Buy Coming Into Year-End appeared first on InvestorPlace.
Biocept to Present Data at RAS-Targeted Drug Development Summit Showing Ability of Its Switch-BlockerTM Technology to Detect Rare Cancer Mutations2021-09-21 08:17
SAN DIEGO--(BUSINESS WIRE)--Biocept presents data showing ultra-sensitive Switch-Blocker technology detects rare cancer mutations at RAS-Targeted Drug Development Summit.
SAN DIEGO--(BUSINESS WIRE)--Biocept (Nasdaq: BIOC), a leading provider of molecular diagnostic assays and services, announces that Michael Nall, President and CEO, will present at four upcoming investor conferences as follows: H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. The presentation can be accessed on the Investor Relations section of the Biocept website beginning Monday, September 13, 2021 at 4:00 a.m. Eastern time (1:00 a.m. Pacific time). Op